Trupanion, Inc (TRUP) is a leading insurance-specialty business based in the US. Trupanion is listed on the NASDAQ and employs 738 staff. All prices are listed in US Dollars.
|52-week range||$22.4752 - $125.574|
|50-day moving average||$113.8436|
|200-day moving average||$81.9674|
|Wall St. target price||$97.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.046|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Trupanion stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Trupanion's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Trupanion's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1485x. In other words, Trupanion shares trade at around 1485x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Trupanion's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5 million.
The EBITDA is a measure of a Trupanion's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$464.8 million|
|Gross profit TTM||$113 million|
|Return on assets TTM||-0.23%|
|Return on equity TTM||-1.23%|
|Market capitalisation||$4.6 billion|
TTM: trailing 12 months
There are currently 2.9 million Trupanion shares held short by investors – that's known as Trupanion's "short interest". This figure is 9.1% down from 3.2 million last month.
There are a few different ways that this level of interest in shorting Trupanion shares can be evaluated.
Trupanion's "short interest ratio" (SIR) is the quantity of Trupanion shares currently shorted divided by the average quantity of Trupanion shares traded daily (recently around 438200.60790274). Trupanion's SIR currently stands at 6.58. In other words for every 100,000 Trupanion shares traded daily on the market, roughly 6580 shares are currently held short.
However Trupanion's short interest can also be evaluated against the total number of Trupanion shares, or, against the total number of tradable Trupanion shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Trupanion's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Trupanion shares in existence, roughly 70 shares are currently held short) or 0.0797% of the tradable shares (for every 100,000 tradable Trupanion shares, roughly 80 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Trupanion.
Find out more about how you can short Trupanion stock.
We're not expecting Trupanion to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Trupanion's shares have ranged in value from as little as $22.4752 up to $125.574. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Trupanion's is 2.0116. This would suggest that Trupanion's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.